Author

Paulameena V. Shultes

Cleveland ClinicORCID 0000-0003-0471-7861Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andriy MarusykiD· 1 shared Arda DurmaziD· 1 shared Dagim Shiferaw TadeleiD· 1 shared Davis T. WeaveriD· 1 shared Endalkachew Ashenafi Alemu· 1 shared Jacob G. ScottiD· 1 shared Mina N. DinhiD· 1 shared Rowan J Barker-ClarkeiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andriy MarusykORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 2, 2024

Cell-Cell Fusion in NSCLC Promotes Evolution of Therapeutic Resistance

Paulameena V. Shultes, Dagim Shiferaw Tadele, Arda Durmaz…·Jacob G. Scott

This study shows that cell-cell fusion in NSCLC leads to increased chemoresistance and tumor aggressiveness by creating hybrid cells with enhanced fitness and genomic heterogeneity.

DOI 10.1101/2024.12.02.626399

humanbulk RNA-seq

𝕏 PostBluesky